Medical Breakthroughs
Platform vs. Point Solution: AI Investment Matrix
The healthcare AI investment landscape is a dynamic arena, characterized by a fundamental tension between two…
Medical Breakthroughs
Medical Breakthroughs
Healthcare AI’s Billion Dollar Failures: Your Next Investment Signal
The landscape of healthcare artificial intelligence has been punctuated by a series of high-profile financial setbacks,…
Medical Breakthroughs
FDA Clearance Isn’t Enough: The Reimbursement Moat for Cardiac AI Wins
The healthcare AI investment landscape is often characterized by a singular focus on regulatory milestones, particularly…
Medical Breakthroughs
Proteus Digital Health: Why $500 Million Failed to Launch
The narrative surrounding healthcare AI investment often spotlights the meteoric rise of innovative technologies, promising transformative…
Medical Breakthroughs
Abe Sutton’s CMMI: Mandatory VBC & AI Investment Outlook
The landscape of healthcare investment is undergoing a profound transformation, driven by policy shifts emanating from…
Medical Breakthroughs
Healthcare AI: Uncovering White Space for 10x Returns
The healthcare AI landscape is rapidly evolving, presenting both immense opportunity and significant analytical challenges for…
Medical Breakthroughs
ECRI: AI Errors Top Hazard. Investors, Re-evaluate Now.
The recent declaration by ECRI, designating AI-generated clinical errors as the number one health technology hazard…
Medical Breakthroughs
CMS’s 10-Year VBC Plan: The AI Investment Mandate
The strategic investor in healthcare AI understands that true disruption isn’t born in a vacuum; it’s…
Medical Breakthroughs
CMS TEAM Model: Investing in AI’s Value-Based Care Future
The landscape of healthcare investment is perpetually reshaped by regulatory shifts, and few entities wield as…
Medical Breakthroughs
Healthcare AI: Platform vs. Point Solution Investment Matrix
The strategic allocation of capital in the burgeoning healthcare AI sector demands a nuanced understanding of…